| Market Capitalization (Millions $) |
2 |
| Shares
Outstanding (Millions) |
2 |
| Employees |
6 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
5 |
| Cash Flow (TTM) (Millions $) |
3 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Protagenic Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative drugs for the treatment of neuropsychiatric disorders. The company is known for its groundbreaking research in targeting the sigma-1 receptor (S1R), an emerging therapeutic target with potential benefits for a range of conditions, including depression, anxiety, and neurodegenerative diseases.
Protagenic Therapeutics utilizes a unique approach called Quantitative Systems Pharmacology (QSP) to identify and develop drugs that modulate the activity of S1R. By comprehensively understanding the intricate molecular pathways involved in neuropsychiatric disorders, the company aims to design precise and effective treatments that can alleviate symptoms and improve patient outcomes.
The company's research efforts have yielded promising results, with several drug candidates in development. Protagenic Therapeutics' lead candidate, PT00114, has shown potential as an antidepressant and cognitive enhancer in preclinical studies. Other candidates in their pipeline target different aspects of neuropsychiatric disorders, such as neuroinflammation and neurodegeneration.
Protagenic Therapeutics is committed to advancing its drug candidates into clinical trials in order to validate their efficacy and safety profiles. The company also collaborates with academic institutions and pharmaceutical partners to accelerate the development process and bring new treatments to patients more efficiently.
Overall, Protagenic Therapeutics Inc is at the forefront of developing novel therapies for neuropsychiatric disorders, utilizing innovative approaches and targeting the sigma-1 receptor to address unmet medical needs in this field.
Company Address: 149 Fifth Avenue New York 10010 NY
Company Phone Number: 994-8200 Stock Exchange / Ticker: NASDAQ PTIX
|
